Original
Eficacia y seguridad de ezetimiba en unidades de riesgo vascular
Efficacy and safety of ezetimibe in vascular risk units
J.L. Díaz Díaza, M. Suárez Tembrab, J.A. Díaz Peromingoc, M. Pena Seijod,
, T. Martínez Ramondee, A. Pose Reinod
Corresponding author
a Servicio de Medicina Interna, CHUAC, A Coruña, España
b Servicio de Medicina Interna, Hospital San Rafael, A Coruña, España
c Servicio de Medicina Interna, Hospital Barbanza, A Coruña, España
d Servicio de Medicina Interna, CHUS, Santiago de Compostela, A Coruña, España
e Servicio de Endocrinología, CHUAC, A Coruña, España
Read
156
Timeswas read the article
156
Total PDF
0
Total HTML
| Year/Month | Html | Total | |
|---|---|---|---|
| 2025 11 | 0 | 8 | 8 |
| 2025 10 | 0 | 9 | 9 |
| 2025 9 | 0 | 7 | 7 |
| 2025 8 | 0 | 9 | 9 |
| 2025 7 | 0 | 2 | 2 |
| 2025 6 | 0 | 8 | 8 |
| 2025 5 | 0 | 4 | 4 |
| 2025 4 | 0 | 5 | 5 |
| 2025 3 | 0 | 4 | 4 |
| 2025 2 | 0 | 6 | 6 |
| 2025 1 | 0 | 10 | 10 |
| 2024 12 | 0 | 4 | 4 |
| 2024 11 | 0 | 3 | 3 |
| 2024 10 | 0 | 3 | 3 |
| 2024 9 | 0 | 8 | 8 |
| 2024 8 | 0 | 4 | 4 |
| 2024 7 | 0 | 5 | 5 |
| 2024 6 | 0 | 2 | 2 |
| 2024 5 | 0 | 6 | 6 |
| 2024 4 | 0 | 4 | 4 |
| 2024 3 | 0 | 7 | 7 |
| 2024 2 | 0 | 3 | 3 |
| 2024 1 | 0 | 2 | 2 |
| 2023 12 | 0 | 5 | 5 |
| 2023 11 | 0 | 3 | 3 |
| 2023 10 | 0 | 5 | 5 |
| 2023 9 | 0 | 13 | 13 |
| 2023 8 | 0 | 1 | 1 |
| 2023 7 | 0 | 2 | 2 |
| 2023 6 | 0 | 3 | 3 |
| 2023 5 | 0 | 1 | 1 |
Show all
